BioSpace News Archive

Launch of the EpiSwitch® Explorer Array Kit expands academic and clinical researcher access to OBD’s EpiSwitch® technology platform following the launch of its EpiSwitch®CST (COVID-19 Severity Test)

BiomX Inc., a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2020.

In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those reported in trial of vaccinated 16-25 year old participants in an earlier analysis, and was well tolerated

NovaBay® Pharmaceuticals, Inc., a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces the availability of its new Warm Eye Compress on Amazon.com and on Avenova.com.

- New capital will fund lead antibody, OR2805, through Phase 1 and 2 clinical studies - Adds Magnetar Group, Yonjin Ventures and Bering Capital to the syndicate

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome

Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, today announced that the Company will host a virtual research and development (R&D) event on April 7 from 1:00 p.m. to 3:00 p.m. ET. The virtual event will include a presentation and interactive Q&A session

Augmedix, Inc. (OTCQX: AUGX), a leading provider of remote medical documentation and live clinical support, today reported financial results for the three months and full year ended December 31, 2020.

People who consume alcohol moderately appear less likely to develop cataracts that require surgery.

Lori Winkler Appointed as Chief Human Resources Officer Sang Yi Promoted to Group President, Asia Pacific with Oversight for Ex-U.S. Channel Management & Portfolio Rationalization Strategy